EP Patent

EP0911333A1 — Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them

Assigned to Pfizer Inc · Expires 1999-04-28 · 27y expired

What this patent protects

Compounds are disclosed which are useful as PDE1 inhibitors. The compounds have the formula:

USPTO Abstract

Compounds are disclosed which are useful as PDE1 inhibitors. The compounds have the formula:

Drugs covered by this patent

Reglan (Metoclopramide Hydrochloride) · Hikma

Patent Metadata

Patent number: EP0911333A1
Jurisdiction: EP
Classification: —
Expires: 1999-04-28
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.